拜耳集团Bayer AG (BAYZF) 2019年年度报告「OTC」.pdf

1、 A Zusammengefasster LageberichtFehler!Kein Text mit angegebener Formatvorlage im Dokument.Bayer-Geschftsbericht 2018 1RESTRICTED Annual Report Bayer Annual Report 2019 Five-Year Summary2Five-Year Summary million 20152016201720182019Bayer Group Sales 46,08534,94335,01536,74243,545EBITDA1 9,5738,8018

2、,5639,6959,554EBITDA before special items1 10,2569,3189,2888,96911,503EBITDA margin before special items1 22.3%26.7%26.5%24.4%26.4%EBIT1 6,2415,7385,9033,4544,189EBIT before special items1 7,0606,8267,1306,0137,007Income before income taxes 5,2364,7734,5771,8862,880Net income(from continuing and dis

3、continued operations)4,1104,5317,3361,6954,091Earnings per share(from continuing and discontinued operations)()1 4.975.448.291.804.17Core earnings per share(from continuing operations)()1 6.826.676.645.606.40Net cash provided by operating activities (from continuing and discontinued operations)6,890

4、9,0898,1347,9178,207Free cash flow()3,8275,8065,2024,6524,214Net financial debt 17,44911,7783,59535,67934,068Capital expenditures(as per segment table)2,5542,6272,4182,3682,920 Bayer AG Total dividend payment 2,0672,2332,4022,6112,751Dividend per share()2.502.702.802.802.80 Innovation Research and d

5、evelopment expenses 4,2744,4054,5045,1055,342Ratio of R&D expenses2 to sales Crop Science(%)10.711.711.713.011.7Ratio of R&D expenses2 to sales Pharmaceuticals(%)16.016.716.215.515.4Ratio of R&D expenses2 to sales Consumer Health(%)3.83.93.94.14.2Employees in research and development 14,75314,21314,

6、04116,83516,006 Employees Number of employees3(Dec.31)116,60099,59299,820107,894103,824Personnel expenses(including pension expenses)(million)11,1769,4599,52810,77811,788Proportion of employees with health insurance(%)9698989898Fluctuation(voluntary/total)(%)5.0/13.94.8/13.24.8/10.45.5/14.86.6/15.0H